Company · CIK 0001534969 · SIC 8071 — Services-Medical Laboratories · Nasdaq
SERA PROGNOSTICS, INC. · SERA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2026 SForm 4 → | Sep 11, 4:07 pm EDT | Dyaarl Lee Anderson Jr.Chief Commercial Officer | 1,800 | $2.00 | $3,600 | 76,198 | −2.31% | |
| Sep 10, 2026 SForm 4 → | Sep 11, 4:07 pm EDT | Zhenya LindgardtChief Executive Officer, Director | 7,022 | $2.00 | $14,044 | 837,848 | −0.83% | |
| Sep 10, 2026 SForm 4 → | Sep 11, 4:07 pm EDT | Tiffany Eul Davis InglisChief Medical Officer | 486 | $2.00 | $972 | 91,589 | −0.53% | |
| Sep 10, 2026 SForm 4 → | Sep 11, 4:07 pm EDT | Benjamin JacksonGeneral Counsel | 2,190 | $2.00 | $4,380 | 159,566 | −1.35% | |
| Sep 8, 2026 SForm 4 → | Sep 9, 4:07 pm EDT | Zhenya LindgardtChief Executive Officer, Director | 20,139 | $2.00 | $40,278 | 844,870 | −2.33% | |
| Aug 31, 2026 AForm 4 → | Sep 1, 5:50 pm EDT | Scott GleasonChief Financial Officer | 117,924 | — | — | 117,924 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 AForm 4 → | Sep 1, 5:50 pm EDT | Scott GleasonChief Financial Officer | 169,624 | — | — | 169,624 | — |